On Friday, Checkpoint Therapeutics Inc (NASDAQ: CKPT) was 0.24% up from the session before settling in for the closing price of $4.09. A 52-week range for CKPT has been $1.38 – $4.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -49.45% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 82.04%. With a float of $64.48 million, this company’s outstanding shares have now reached $87.02 million.
In an organization with 24 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -31551.22%, operating margin of -137009.76%, and the pretax margin is -137170.73%.
Checkpoint Therapeutics Inc (CKPT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Checkpoint Therapeutics Inc stocks. The insider ownership of Checkpoint Therapeutics Inc is 25.90%, while institutional ownership is 23.18%. The most recent insider transaction that took place on Apr 02 ’25, was worth 60,964. In this transaction CEO, President and Director of this company sold 15,090 shares at a rate of $4.04, taking the stock ownership to the 3,759,929 shares. Before that another transaction happened on Apr 01 ’25, when Company’s Chief Financial Officer sold 12,322 for $4.05, making the entire transaction worth $49,904. This insider now owns 1,446,322 shares in total.
Checkpoint Therapeutics Inc (CKPT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 82.04% per share during the next fiscal year.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Trading Performance Indicators
You can see what Checkpoint Therapeutics Inc (CKPT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8919.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.27, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 1.13 in one year’s time.
Technical Analysis of Checkpoint Therapeutics Inc (CKPT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.17 million. That was inferior than the volume of 2.3 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 93.73%. Additionally, its Average True Range was 0.06.
During the past 100 days, Checkpoint Therapeutics Inc’s (CKPT) raw stochastic average was set at 81.26%, which indicates a significant decrease from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 9.01% in the past 14 days, which was lower than the 99.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.66, while its 200-day Moving Average is $3.12. However, in the short run, Checkpoint Therapeutics Inc’s stock first resistance to watch stands at $4.11. Second resistance stands at $4.11. The third major resistance level sits at $4.13. If the price goes on to break the first support level at $4.09, it is likely to go to the next support level at $4.07. The third support level lies at $4.07 if the price breaches the second support level.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Key Stats
There are 83,764K outstanding shares of the company, which has a market capitalization of 356.78 million. As of now, sales total 40 K while income totals -56,240 K. Its latest quarter income was 0 K while its last quarter net income were -9,730 K.
